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o Identification and feedback traceability of a meat cut, ideally, at the level of final selling point
o Functioning of an electronic data base with unalterable and accessible to the consumer data
Additionally the same agency will be responsible for:
o Developing and supervising the application, by its members, the regulations governing the
internal functioning of the system
o Training of its members for the in practice application of the system
o The internal auditing of the system
o Linking together, in an integrated way all participating units in the system.
In Fig. 1 the whole system is summarily illustrated. 
Conclusion: Under these conditions the distribution of certified pork in the market, supported with
accessibility of the consumer to all information stored in the data bank, operating by the agency
functioning and supervising the system, will be recognized trough its special trade mark in connection
with the trade mark of AGROCERT. Further it is hoped that the product will enjoy premium prices. 
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Summary: Salmonellosis is a common clinical and subclinical infection of pigs. The species adapted
serovar S choleraesuis predominantly produces a septicemic disease in swine. Disease in other
species, including humans, is rare compared to enteric type infections from non host adapted serovars
such as S typhimurium. However, when host adapted serovars infect alternate species, disease can
be severe. Vaccination with an avirulent live S choleraesuis vaccine, Enterisol® SC-54, significantly
reduces prevalence and quantity of infection in pigs. Additionally, those pigs that remain culture
positive have two logs or more reduction in the quantity of S choleraesuis present. Vaccination of
pigs as young as one day of age is successful. Where these infections are of concern in the human
population, vaccination of pigs may provide dramatic reductions of the organism swine, reducing
risk in food items of swine origin.
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Introduction: Salmonella infections in pork have been linked to outbreaks of food born disease in
humans. Those practices that reduce the level of contamination or carriage of Salmonella in carcasses
that arrive at abattoirs should assist in reducing contamination of post-harvest pork products. In
some cases, Salmonella choleraesuis, a host adapted Salmonella, may play an important role in
human disease. While typically a rare infection in humans, some countries report significant problems
with S choleraesuis infections in humans (Chui et al., 2002). In some areas, the prevalence of S
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choleraesuis may reach 5% or more of all Salmonellae isolated from human samples (Chui et al.,
2002). When these isolates become resistant to primary treatment antibiotics, other methods for
preventing exposure to people from the resident source, swine, may increase in importance. Challenge
control studies were performed to gain USDA licensure of a live, avirulent S choleraesuis vaccine,
Enterisol® SC-54 (Boehringer Ingelheim Animal Health GmbH). This vaccine was developed by serial
passage through neutrophils. One of the mechanisms of attenuation was natural loss of the virulence
plasmid, vpl, during passage (Roof et al., 1992). The vaccine is fully licensed as safe and efficacious
by the USDA and numerous countries throughout the world. This paper summarizes data on reducing
the prevalence of S choleraesuis by vaccination.
Materials and Methods: Pigs for challenge studies were selected from herds free of clinical signs of
salmonellosis in the nursery. For each study, pigs were weighed and blocked by sex and weight into
strict control (non vaccinated, non challenged), challenge control and vaccinated/challenged.
Group sizes ranged from 10 to 20 pigs for each study group. Vaccine was administered either
intranasally or orally, via drinking water, to mimic the natural route of exposure. Animals were housed
in separate rooms prior to and during challenge to reduce exposure between groups. The interval
from vaccination to challenge ranged from 14 days to 140 days. Pigs were monitored for 14 days
following challenge for clinical signs and weight gain. All surviving animals were humanely euthanized
at the end of the challenge period. Studies were performed both internally, and by independent
laboratories (Baum, 1997).
Results: Data from studies comparing Enterisol® SC-54 to non vaccinated control pigs challenged
with S choleraesuis. Various tissues were examined for presence (+/-) and quantity (log cfu/gm tissue)
of the challenge organism. A biochemical marker was used to differentiate the vaccine from challenge
strains. When pigs were vaccinated at three weeks of age or older, either intranasally or orally, via
drinking water, pigs were clinically protected from challenge for at least 20 weeks following vaccination.
Additionally, both the prevalence and quantity of S choleraesuis in internal organs were significantly
reduced. Reduction of 1 log or more, and 50% lower rate of organ colonization was noted, all significant
at p<0.05.
An additional efficacy study was performed in order to obtain a license to vaccinated pigs at one
days of age. Cohort pigs were vaccinated intranasally at one day of age, three weeks of age, or left
as strict or challenge control pigs. Challenge with 1010 virulent S choleraesuis occurred at 34 days of
age. Pigs were monitored for 14 days following challenge.
As compared to both control and 21 day vaccinated pigs, the group of pigs vaccinated at one day
of age had lower culture prevalence and cfu/gm of tissue of the challenge strain (Table one). Daily
gain, temperature post challenge and mortality were nominally improved for one day vs. 21 day
vaccination. All vaccinated pigs were significantly improved over control pigs. Organ protection from
colonization was significantly improved for one day vaccinated pigs, as compared to both controls
and 21 day old vaccinates, which performed consistently with prior studies.
Table 1. Summary of Clinical and Organ Colonization on Salmonella choleraesuis challenge
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Discussion: Immunization with an avirulent live S choleraesuis vaccine has demonstrated consistent
clinical and bacteriologic control of S choleraesuis infections in swine. Clinical signs, including febrile
response, diarrhea and mortality, along with growth rate, are significantly improved (p<0.05). Pigs
from one day of age and older may be safety vaccinated intranasally, or orally, via drinking water,
against disease associated with S choleraesuis, and to reduce the culture prevalence and shedding
of other serovars of Salmonellae (Nolan et al., 2000). Additionally, levels of the organism are effectively
reduced in vaccinated, challenged pigs. Fecal shedding of S choleraesuis is significantly lower in
vaccinated challenged pigs as compared to challenged control pigs. Organ culture prevalence is
likewise dramatically lowered in vaccinated pigs. Vaccination at one day of age is at least as
efficacious, and may offer even greater advantage over non vaccinated controls. 
References:
Baum, D. (1997): PhD Thesis, Iowa State University
Chui, C-H., Wu, T-S., Su, L-H., Chu, C., Chia, J-S.,Kuo, A-J., Chien, M-S., Lin, T-Y. (2002): The emergence in Taiwan of Fluoroquinalone
resistance in Salmonella enterica serovar choleraesuis. New Eng J Med 346, 413-419.
Nolan, D., Baum D., Fleck, R., Worstell, J., Kolb, J., Kahle, D. (2000): Use of Process Behavior Charts for the purpose of continuous
improvement in swine production. Proc Am Assn Swine Pract. 219-224.
Roof, M., Kramer T., Roth, J., Minion F. (1992): Characterization of a Salmonella choleraesuis isolate after repeated neutrophil
exposure. Am J Vet Res 53, 1328-1332.
Roof, M., Doitchinoff, D. (1995): Safety, efficacy and duration of immunity induced in swine by use of an avirulent live Salmonella
choleraesuis - containing vaccine. Am J Vet Res 56, 39-44.
Reduction of salmonella contamination 
in pork carcasses by vaccination
J Kolb*, M Roof, K Burkhart
2501 North Loop Drive, Ames, Iowa USA 50010, jkolb@bi-vetmedica.com, Phone +1-515-203-0092 Fax +1-515-268-1760
Summary: Two field studies and one laboratory challenge were performed to evaluate of vaccination
with a live, avirulent Salmonella choleraesuis vaccine (Enterisol® SC-54) to provide cross protection,
reduce the level of internal culture and fecal shedding of multiple serovars of Salmonella. Barns of
grow-finish pigs were vaccinated orally, via drinking water, or left as matched controls in the field studies.
Ileocecal lymph nodes and spiral colon fecal material were collected at the abattoir from field
studies. Three week old pigs were vaccinated intranasally and challenged at five weeks of age in
the laboratory study. Internal organ culture and fecal shedding were measured two weeks following
challenge with S typhimurium. In all three studies, vaccinated pigs had significantly lower culture
prevalence of non S choleraesuis serovars (p<0.05), and reduced fecal shedding in following laboratory
challenge (p<0.05). A nominal (p=0.07) trend to improved growth rate following laboratory challenge
with S typhimurium challenge was also detected.
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Introduction: Salmonella infections in pork have been linked to outbreaks of food born disease in
humans, attracting attention to those strategies that may help reduce Salmonella in pork (Letellier
et al., 2001). Those practices that reduce the level of contamination or carriage of Salmonella in
carcasses that arrive at abattoirs should assist in reducing Salmonella contamination of post-harvest
pork products. Enterisol® SC-54 (Boehringer Ingelheim Animal Health GmbH), an avirulent live Salmonella
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